How an NCI Data Registry is Helping Diagnose, Treat Rare Pediatric Cancers
The Rare Cancer Initiative is enabling the research community to access more clinical data to improve health outcomes for children diagnosed with rare cancers.
A special initiative and data registry at the National Cancer Institute is helping researchers understand and treat rare childhood cancers.
Dr. Mary Frances Wedekind, a pediatric oncologist and assistant research physician with the Pediatric Oncology Branch at NCI, explains how the Childhood Cancer Data Initiative follows children, teens and young adults for many years to collect key information about their cancer diagnosis, imaging and treatments.
She added that the initiative along with the Rare Cancer Data Registry are critical to helping researchers access and analyze the clinical and genomic data that could potentially lead to more effective targeted therapies and new drug developments that could improve the standards of care for young patients.
-
Dr. Mary Frances Wedekind Pediatric Oncologist and Assistant Research Physician with the Pediatric Oncology Branch NCI
-
Building Resilient Teams: Culture Eats Strategy for Breakfast
Jamie Holcombe shares how trust, mission clarity and employee well-being help leaders build resilient teams and sustain innovation.
24m watch -
Streamlining the ATO Process Makes Software Deployments More Efficient, Secure
NIST’s Victoria Yan Pillitteri discusses common ATO stumbling blocks and how agencies can streamline authorization for secure software deployment.
7m watch -
This National Lab is Using Multi-Agent AI to Accelerate Scientific Discovery
SLAC’s John Sarrao details how AI is accelerating materials discovery and reshaping collaboration across national labs and federal agencies.
21m watch -
DOT Advisor: Federal Contracting Must Adapt to Keep Pace With AI
AI is advancing faster than federal procurement cycles, making modular contracts, AI disclosure and new pricing models increasingly critical.
11m watch
